Details for New Drug Application (NDA): 209162
✉ Email this page to a colleague
The generic ingredient in CHLORTHALIDONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
Summary for 209162
| Tradename: | CHLORTHALIDONE |
| Applicant: | Ipca Labs Ltd |
| Ingredient: | chlorthalidone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 209162
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
| Approval Date: | Nov 12, 2024 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
| Approval Date: | Nov 12, 2024 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
